| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 75, 1289-1292, Copyright © 1992 by Endocrine Society
ARTICLES |
R Medlej, JM Lobaccaro, P Berta, C Belon, B Leheup, JE Toublanc, J Weill, C Chevalier, R Dumas and C Sultan
Unite de Biochimie Endocrinienne du Developpement et de la Reproduction, Hopital Lapeyronie, Montpellier, France.
In Turner patients, the presence of a Y chromosome or derivative Y is correlated with the risk of gonadoblastoma induction. "Marker" chromosomes originating from Y, may not show characteristic fluorescence and then be very difficult to identify by conventional cytogenetic techniques, although they still predispose the patients to gonadal tumors. Using polymerase chain reaction of the gene from the sex-determining region of the Y chromosome, we screened 40 Turner patients (thirty seven 45X and three 45X,46XX) for the presence of Y chromosomal DNA. We were able to identify karyotypically unrecognized Y chromosome material in 1 patient out of the 40 studied. In this patient mild clinical and biological hyperandrogenism was observed. Reliability of our technique was ascertained by the detection of the expected 648 base pairs amplified DNA fragment in all normal male controls as well as in 3 Turner patients with confirmed 45X,46XY mosaicism. Despite the low frequency of unrecognized Y chromosome material (1 case over 40 in our experience), our data suggest that polymerase chain reaction of the gene from the sex-determining region of the Y chromosome is worthy of being performed in Turner patients considering the potential risk of the presence of a Y chromosome.
This article has been cited by other articles:
![]() |
M. Cools, S. L. S. Drop, K. P. Wolffenbuttel, J. W. Oosterhuis, and L. H. J. Looijenga Germ Cell Tumors in the Intersex Gonad: Old Paths, New Directions, Moving Frontiers Endocr. Rev., August 1, 2006; 27(5): 468 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bashamboo, M. M. Rahman, A. Prasad, S. P. Chandy, J. Ahmad, and S. Ali Fate of SRY, PABY, DYS1, DYZ3 and DYZ1 loci in Indian patients harbouring sex chromosomal anomalies Mol. Hum. Reprod., February 1, 2005; 11(2): 117 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Gravholt, J. Fedder, R. W. Naeraa, and J. Müller Occurrence of Gonadoblastoma in Females with Turner Syndrome and Y Chromosome Material: A Population Study J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3199 - 3202. [Abstract] [Full Text] |
||||
![]() |
D O Robinson, P Dalton, P A Jacobs, K Mosse, M M Power, D H Skuse, and J A Crolla A molecular and FISH analysis of structurally abnormal Y chromosomes in patients with Turner syndrome J. Med. Genet., April 1, 1999; 36(4): 279 - 284. [Abstract] [Full Text] |
||||
![]() |
C. Gicquel, V. Gaston, S. Cabrol, and Y. Le Bouc Assessment of Turner's Syndrome by Molecular Analysis of the X Chromosome in Growth-Retarded Girls J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1472 - 1476. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |